GAMMA Investing’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.3K Buy
1,229
+11
+0.9% +$99 ﹤0.01% 3102
2026
Q1
$11.6K Buy
1,218
+977
+405% +$7.59K ﹤0.01% 2998
2025
Q4
$1.88K Sell
241
-104
-30% -$752 ﹤0.01% 3620
2025
Q3
$2.62K Sell
345
-70
-17% -$583 ﹤0.01% 3379
2025
Q2
$3.72K Sell
415
-374
-47% -$3.48K ﹤0.01% 3224
2025
Q1
$5.92K Buy
789
+320
+68% +$2.58K ﹤0.01% 3015
2024
Q4
$3.53K Buy
469
+124
+36% +$941 ﹤0.01% 3049
2024
Q3
$2.62K Buy
345
+191
+124% +$1.45K ﹤0.01% 2981
2024
Q2
$952 Buy
154
+46
+43% +$254 ﹤0.01% 3069
2024
Q1
$549 Buy
108
+1
+0.9% +$6 ﹤0.01% 3091
2023
Q4
$567 Buy
+107
New +$620 ﹤0.01% 2936

Other funds holding BCRX